Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$0.57 - $1.16 $370 - $754
-650 Reduced 4.74%
13,055 $7,000
Q4 2022

Feb 14, 2023

SELL
$1.4 - $25.4 $61 - $1,117
-44 Reduced 0.32%
13,705 $20,000
Q3 2022

Nov 10, 2022

SELL
$0.36 - $36.0 $488 - $48,816
-1,356 Reduced 8.98%
13,749 $25,000
Q1 2022

May 13, 2022

SELL
$16.6 - $32.3 $99,600 - $193,799
-6,000 Reduced 28.43%
15,105 $39,000
Q4 2021

Feb 14, 2022

BUY
$29.9 - $61.2 $140,530 - $287,640
4,700 Added 28.65%
21,105 $63,000
Q3 2021

Nov 16, 2021

SELL
$51.4 - $68.2 $221,020 - $293,260
-4,300 Reduced 20.77%
16,405 $90,000
Q2 2021

Aug 13, 2021

BUY
$44.1 - $84.0 $295,470 - $562,800
6,700 Added 47.84%
20,705 $152,000
Q1 2021

May 17, 2021

BUY
$47.0 - $155.7 $658,235 - $2.18 Million
14,005 New
14,005 $113,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $58M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.